Santaris Pharma A/S of Denmark has entered into a strategic alliance with Roche to discover and develop RNA-targeted medicines using locked nucleic acid technology which has been developed by Santaris. ---Subscribe to MedNous to access this article--- Company News Finance, Grants, Deals
